Although MMP-9 has been reported to exert context-dependent neuroprotective effects, such as promoting amyloid-beta clearance in Alzheimer’s disease models (32) our findings suggest that in COPD-associated depression, its pathogenic effects predominate. This evidence concerns the gene MMP9 and early-onset autosomal dominant Alzheimer disease.